サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：PoC (ポイントオブケア) 診断の世界市場の分析 (2023年～2033年)
市場調査レポート
商品コード
1181118

PoC (ポイントオブケア) 診断の世界市場の分析 (2023年～2033年)

Point of Care Diagnostics Market Report 2023-2033
出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 352 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=196.32円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

PoC (ポイントオブケア) 診断の世界市場の分析 (2023年～2033年)
出版日: 2023年01月03日
発行: Visiongain Reports Ltd.
ページ情報: 英文 352 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のPoC (ポイントオブケア) 診断の市場規模は、2033年までに8.8%のCAGRで成長すると予測されています。

市場の主な促進要因として、検査対象の疾患 (糖尿病・血友病・がん・心疾患など) の発症件数の増加や、CLIA免除PoC検査の件数増加などが挙げられます。PoC検査の対象疾患は継続的なモニタリングが必要なため、その発症率・有病率の上昇が市場規模にも大きく影響しています。

当レポートでは、世界のPoC診断の市場について分析し、製品の概要や市場の基本構造・最新情勢、主な促進・抑制要因、市場規模の推定値・予測値 (2023年～2033年)、製品別・モード別・標本別・プラットフォーム別・エンドユーザー別および地域別・主要国の詳細動向、主要企業のプロファイル、COVID-19の影響と回復シナリオ、といった情報を取りまとめてお届けいたします。

目次

第1章 分析概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な分析結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • 新型コロナウイルス感染症 (COVID-19) の影響分析
  • ポーターのファイブフォース分析
  • PEST分析
  • SWOT分析

第4章 PoC診断市場：製品別 (2023年～2033年)

  • 主な分析結果
  • 市場魅力指数：製品別
  • 市場規模の推定・予測：製品別
  • 血糖モニタリング
    • 市場規模：地域別 (単位：10億米ドル、2023年～2033年)
    • 市場シェア：地域別 (2023年・2033年)
  • 心臓代謝モニタリング
  • 感染症検査
  • 凝固モニタリング
  • 妊娠・不妊検査
  • 腫瘍・がんマーカー検査
  • 尿検査
  • コレステロール検査
  • 血液検査
  • 乱用薬物 (DOA) 検査
  • 便潜血検査
  • その他のPOC製品

第5章 PoC診断市場：モード別 (2023年～2033年)

  • 主な分析結果
  • 市場魅力指数：モード別
  • 市場規模の推定・予測：モード別
  • 処方箋ベース製品
  • 店頭販売 (OTC) 商品

第6章 PoC診断市場：標本別 (2023年～2033年)

  • 主な分析結果
  • 市場魅力指数：標本別
  • 市場規模の推定・予測：標本別
  • 血液
  • 鼻腔・中咽頭スワブ
  • 尿
  • その他

第7章 PoC診断市場：プラットフォーム別 (2023年～2033年)

  • 主な分析結果
  • 市場魅力指数：プラットフォーム別
  • 市場規模の推定・予測：プラットフォーム別
  • ラテラルフローアッセイ
  • ディップスティック
  • マイクロ流体
  • 分子診断
  • イムノアッセイ

第8章 PoC診断市場：エンドユーザー別 (2023年～2033年)

  • 主な分析結果
  • 市場魅力指数：エンドユーザー別
  • 市場規模の推定・予測：エンドユーザー別
  • 診療所
  • 病院
  • 在宅医療
  • その他のエンドユーザー

第9章 PoC診断市場：地域別 (2023年～2033年)

  • 主な分析結果
  • 市場規模の推定・予測：地域別

第10章 北米のPoC診断市場 (2023年～2033年)

  • 主な分析結果
  • 北米のPoC診断市場の魅力指数
  • 北米のPoC診断市場：国別 (単位：10億米ドル、2023年・2028年・2033年)
  • 北米市場の推定・予測：製品別
  • 北米市場の推定・予測：モード別
  • 北米市場の推定・予測：標本別
  • 北米市場の推定・予測：プラットフォーム別
  • 北米市場の推定・予測：エンドユーザー別
  • 北米市場の推定・予測：国別
  • 米国市場の分析
  • カナダ市場の分析

第11章 欧州のPoC診断市場 (2023年～2033年)

  • 主な分析結果
  • 欧州のPoC診断市場の魅力指数
  • 欧州のPoC診断市場：国別 (単位：10億米ドル、2023年・2028年・2033年)
  • 欧州市場の推定・予測：国別
  • 欧州市場の推定・予測：製品別
  • 欧州市場の推定・予測：モード別
  • 欧州市場の推定・予測：標本別
  • 欧州市場の推定・予測：プラットフォーム別
  • 欧州市場の推定・予測：エンドユーザー別
  • ドイツ市場の分析
  • 英国市場の分析
  • フランス市場の分析
  • イタリア市場の分析
  • スペイン市場の分析
  • オランダ市場の分析
  • 他の欧州諸国の市場の分析

第12章 アジア太平洋のPoC診断市場 (2023年～2033年)

  • 主な分析結果
  • アジア太平洋のPoC診断市場の魅力指数
  • アジア太平洋のPoC診断市場：国別 (単位：10億米ドル、2023年・2028年・2033年)
  • アジア太平洋市場の推定・予測：国別
  • アジア太平洋市場の推定・予測：製品別
  • アジア太平洋市場の推定・予測：モード別
  • アジア太平洋市場の推定・予測：標本別
  • アジア太平洋市場の推定・予測：プラットフォーム別
  • アジア太平洋市場の推定・予測：エンドユーザー別
  • 日本市場の分析
  • 中国市場の分析
  • インド市場の分析
  • オーストラリア市場の分析
  • 韓国市場の分析
  • 他のアジア太平洋諸国の市場の分析

第13章 ラテンアメリカのPoC診断市場 (2023年～2033年)

  • 主な分析結果
  • ラテンアメリカのPoC診断市場の魅力指数
  • ラテンアメリカのPoC診断市場：国別 (単位：10億米ドル、2023年・2028年・2033年)
  • ラテンアメリカ市場の推定・予測：国別
  • ラテンアメリカ市場の推定・予測：製品別
  • ラテンアメリカ市場の推定・予測：モード別
  • ラテンアメリカ市場の推定・予測：標本別
  • ラテンアメリカ市場の推定・予測：プラットフォーム別
  • ラテンアメリカ市場の推定・予測：エンドユーザー別
  • ブラジル市場の分析
  • メキシコ市場の分析
  • 他のラテンアメリカ諸国の市場の分析

第14章 中東・アフリカのPoC診断市場 (2023年～2033年)

  • 主な分析結果
  • 中東・アフリカのPoC診断市場の魅力指数
  • 中東・アフリカのPoC診断市場：国別 (単位：10億米ドル、2023年・2028年・2033年)
  • 中東・アフリカ市場の推定・予測：国別
  • 中東・アフリカ市場の推定・予測：製品別
  • 中東・アフリカ市場の推定・予測：モード別
  • 中東・アフリカ市場の推定・予測：標本別
  • 中東・アフリカ市場の推定・予測：プラットフォーム別
  • 中東・アフリカ市場の推定・予測：エンドユーザー別
  • 湾岸協力会議 (GCC) 諸国の市場の分析
  • 南アフリカ市場の分析
  • 他の中東・アフリカ諸国の市場の分析

第15章 企業プロファイル

  • 競合情勢 (2021年)
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Quidel Corporation
  • AccuBioTech Co., Ltd
  • Thermo Fisher Scientific
  • BD
  • Danaher
  • PTS Diagnostics
  • Trinity Biotech Ireland
  • Siemens Healthcare GmbH
  • Sekisui Diagnostics
  • Fluxergy
  • Chembio Diagnostics Inc.
  • Werfen
  • NOVA BIOMEDICAL
  • Qiagen
  • bioMerieux SA
  • Nipro Europe Group Companies
  • EKF Diagnostics Holdings plc
  • TRIVIDIA HEALTH, INC.
  • Spectral Medical Inc.
  • Orasure Technologies, Inc.
  • Response Biomedical
  • LumiraDX
  • Meridian Bioscience Inc.

第16章 結論と提言

図表

List of Tables

  • Table 1 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): "V" Shaped Recovery Scenario
  • Table 2 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): "U" Shaped Recovery Scenario
  • Table 3 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): "W" Shaped Recovery Scenario
  • Table 4 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): "L" Shaped Recovery Scenario
  • Table 5 Point of Care Diagnostics Market Forecast By Product, 2023-2033 (US$ Bn, AGR%, CAGR%)
  • Table 6 Glucose Monitoring Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 7 Cardiometabolic Monitoring Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 8 Infectious Disease Testing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 9 Coagulation Monitoring Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 10 Pregnancy & Fertility Testing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 11 Tumour/Cancer Marker Testing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 12 Urinalysis Testing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 13 Cholesterol Testing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 14 Hematology Testing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 15 Drugs-of-abuse Testing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 16 Fecal Occult Testing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 17 Other POC Products Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 18 Point of Care Diagnostics Market by Mode, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 19 Prescription-based Products Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 20 OTC Products Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 21 Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 22 Blood Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 23 Nasal and Oropharyngeal Swabs Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 24 Urine Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 25 Other Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 26 Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 27 Lateral Flow Assay Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 28 Dipstick Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 29 Microfluidics Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 30 Molecular diagnostics Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 31 Immunoassay Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 32 Point of Care Diagnostics Market Forecast By End User, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 33 Clinics Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 34 Hospitals Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 35 Home Care Settings Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 36 Other End-users Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 37 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%))
  • Table 38 North America Point of Care Diagnostics Market Forecast By Products, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 39 North America Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 40 North America Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 41 North America Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 42 North America Point of Care Diagnostics Market Forecast by End Users, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 43 North America Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 44 U.S. Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 45 Canada Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 46 Europe Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 47 Europe Point of Care Diagnostics Market Forecast By Product, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 48 Europe Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 49 Europe Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 50 Europe Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 51 Europe Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 52 Germany Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 53 UK Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 54 France Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 55 Italy Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 56 Spain Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 57 Netherlands Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 58 Rest of Europe Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 59 Asia Pacific Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 60 Asia Pacific Point of Care Diagnostics Market Forecast By Product, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 61 Asia Pacific Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 62 Asia Pacific Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 63 Asia Pacific Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 64 Asia Pacific Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 65 Japan Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 66 China Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 67 India Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 68 Australia Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 69 South Korea Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 70 Rest of Asia Pacific Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 71 Latin America Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 72 Latin America Point of Care Diagnostics Market Forecast by Product, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 73 Latin America Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 74 Latin America Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 75 Latin America Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 76 Latin America Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 77 Brazil Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 78 Mexico Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 79 Rest of Latin America Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 80 MEA Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 81 MEA Point of Care Diagnostics Market Forecast by Product, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 82 MEA Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 83 MEA Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 84 MEA Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 85 MEA Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 86 GCC Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 87 South Africa Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 88 Rest of MEA Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 89 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 90 Abbott: Product Benchmarking
  • Table 91 Abbott: Strategic Outlook
  • Table 92 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 F. Hoffmann-La Roche Ltd: Product Benchmarking
  • Table 94 F. Hoffmann-La Roche Ltd: Strategic Outlook
  • Table 95 Quidel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 Quidel Corporation: Product Benchmarking
  • Table 97 Quidel Ortho Corporation: Strategic Outlook
  • Table 98 AccuBioTech Co., Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 AccuBioTech Co., Ltd: Product Benchmarking
  • Table 100 AccuBioTech Co., Ltd: Strategic Outlook
  • Table 101 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Thermo Fisher Scientific.: Product Benchmarking
  • Table 103 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 104 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 BD: Product Benchmarking
  • Table 106 BD: Strategic Outlook
  • Table 107 Danaher: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 Danaher: Product Benchmarking
  • Table 109 Danaher: Strategic Outlook
  • Table 110 PTS Diagnostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 PTS Diagnostics: Product Benchmarking
  • Table 112 Trinity Biotech Ireland: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Trinity Biotech Ireland: Product Benchmarking
  • Table 114 Trinity Biotech Ireland: Strategic Outlook
  • Table 115 Siemens Healthcare GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 116 Siemens Healthcare GmbH: Product Benchmarking
  • Table 117 Siemens Healthcare GmbH: Strategic Outlook
  • Table 118 Sekisui Diagnostics: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 119 Sekisui Diagnostics: Product Benchmarking
  • Table 120 Sekisui Diagnostics: Strategic Outlook
  • Table 121 Fluxergy: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 122 Fluxergy: Product Benchmarking
  • Table 123 Fluxergy: Strategic Outlook
  • Table 124 Chembio Diagnostics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 125 Chembio Diagnostics: Inc. Product Benchmarking
  • Table 126 Chembio Diagnostics Inc.: Strategic Outlook
  • Table 127 Werfen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 128 Werfen: Product Benchmarking
  • Table 129 Nova Biomedical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 130 Nova Biomedical: Product Benchmarking
  • Table 131 Qiagen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 132 Qiagen: Product Benchmarking
  • Table 133 Qiagen: Strategic Outlook
  • Table 134 bioMerieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 135 bioMerieux SA: Product Benchmarking
  • Table 136 bioMerieux SA: Strategic Outlook
  • Table 137 Nipro Europe Group Companies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 138 Nipro Europe Group Companies: Product Benchmarking
  • Table 139 Nipro Europe Group Companies: Strategic Outlook
  • Table 140 EKF Diagnostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 141 EKF Diagnostics: Product Benchmarking
  • Table 142 EKF Diagnostics: Strategic Outlook
  • Table 143 Trividia Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 144 Trividia Health, Inc.: Product Benchmarking
  • Table 145 Spectral Medical Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 146 Spectral Medical Inc.: Product Benchmarking
  • Table 147 Orasure Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 148 Orasure Technologies, Inc.: Product Benchmarking
  • Table 149 Orasure Technologies, Inc.: Strategic Outlook
  • Table 150 Response Biomedical.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 151 Response Biomedical: Product Benchmarking
  • Table 152 Response Biomedical.: Strategic Outlook
  • Table 153 LumiraDX.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 154 LumiraDX.: Product Benchmarking
  • Table 155 LumiraDX.: Strategic Outlook
  • Table 156 Meridian Bioscience Inc..: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 157 Meridian Bioscience Inc..: Product Benchmarking
  • Table 158 Meridian Bioscience Inc..: Strategic Outlook
  •  

List of Figures

  • Figure 1 Point of Care Diagnostics Market Segmentation
  • Figure 2 Global Point of Care Diagnostics by Region: Market Attractiveness Index
  • Figure 3 Point of Care Diagnostics Market by Product: Market Attractiveness Index
  • Figure 4 Point of Care Diagnostics Market by Mode: Market Attractiveness Index
  • Figure 5 Point of Care Diagnostics Market: Market Dynamics
  • Figure 6 COVID Impact Analysis: Point of Care Diagnostics Market Recovery Scenarios
  • Figure 7 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR %): "V" Shaped Recovery
  • Figure 8 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR %): "U" Shaped Recovery
  • Figure 9 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR %): "W" Shaped Recovery
  • Figure 10 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR %): "L" Shaped Recovery
  • Figure 11 Point of Care Diagnostics Market: Porter's Five Forces Analysis
  • Figure 12 Point of Care Diagnostics Market: PEST Analysis
  • Figure 13 Global Point of Care Diagnostics Market: SWOT Analysis
  • Figure 14 Point of Care Diagnostics Market by Product Segment: Market Attractiveness Index
  • Figure 15 Point of Care Diagnostics Market Forecast By Product, 2023-2033 (US$ bn)
  • Figure 16 Point of Care Diagnostics Market Share Forecast By Product, 2023, 2028, 2033 (%)
  • Figure 17 Glucose Monitoring Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 18 Glucose Monitoring Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 19 Cardiometabolic Monitoring Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 20 Cardiometabolic Monitoring Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 21 Infectious Disease Testing Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 22 Infectious Disease Testing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 23 Coagulation Monitoring Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 24 Coagulation Monitoring Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 25 Pregnancy & Fertility Testing Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 26 Pregnancy & Fertility Testing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 27 Tumour/Cancer Marker Testing Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 28 Tumour/Cancer Marker Testing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 29 Urinalysis Testing Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 30 Urinalysis Testing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 31 Cholesterol Testing Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 32 Cholesterol Testing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 33 Hematology Testing Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 34 Hematology Testing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 35 Drugs-of-abuse Testing Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 36 Drugs-of-abuse Testing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 37 Fecal Occult Testing Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 38 Fecal Occult Testing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 39 Other POC Products Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 40 Other POC Products Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 41 Point of Care Diagnostics Market by Mode Segment: Market Attractiveness Index
  • Figure 42 Point of Care Diagnostics Market by Mode, 2023-2033 (US$ bn)
  • Figure 43 Point of Care Diagnostics Market Share Forecast By Mode, 2023, 2028, 2033 (%)
  • Figure 44 Prescription-based Products Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 45 Prescription-based Products Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 46 OTC Products Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 47 OTC Products Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 48 Point of Care Diagnostics Market by Sample Segment: Market Attractiveness Index
  • Figure 49 Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn)
  • Figure 50 Point of Care Diagnostics Market Share Forecast by Sample, 2023, 2028, 2033 (%)
  • Figure 51 Blood Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 52 Blood Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 53 Nasal and Oropharyngeal Swabs Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 54 Nasal and Oropharyngeal Swabs Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 55 Urine Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 56 Urine Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 57 Other Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 58 Other Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 59 Point of Care Diagnostics Market by Platform Segment: Market Attractiveness Index
  • Figure 60 Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn)
  • Figure 61 Point of Care Diagnostics Market Share Forecast by Platform, 2023, 2028, 2033 (%)
  • Figure 62 Lateral Flow Assay Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 63 Lateral Flow Assay Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 64 Dipstick Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 65 Dipstick Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 66 Microfluidics Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 67 Microfluidics Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 68 Molecular diagnostics Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 69 Molecular diagnostics Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 70 Immunoassay Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 71 Immunoassay Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 72 Point of Care Diagnostics Market by End User: Market Attractiveness Index
  • Figure 73 Point of Care Diagnostics Market Forecast by End User, 2023-2033 (US$ bn)
  • Figure 74 Point of Care Diagnostics Market Share Forecast by End User, 2023, 2028, 2033 (%)
  • Figure 75 Clinics Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 76 Clinics Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 77 Hospitals Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 78 Hospitals Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 79 Home Care Settings Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 80 Home Care Settings Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 81 Other End-users Market Forecast by Region, 2023-2033 (US$ bn)
  • Figure 82 Other End-users Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 83 Point of Care Diagnostics Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
  • Figure 84 Point of Care Diagnostics Market Share Forecast by Region 2023, 2028, 2033(%)
  • Figure 85 Point of Care Diagnostics Market by Region, 2023-2033 (US$ bn, AGR %)
  • Figure 86 North America Point of Care Diagnostics Market Attractiveness Index
  • Figure 87 North America Point of Care Diagnostics Market by Region, 2023, 2028 & 2033 (US$ bn)
  • Figure 88 North America Point of Care Diagnostics Market Forecast By Products, 2023-2033 (US$ bn)
  • Figure 89 North America Point of Care Diagnostics Market Share Forecast By Products, 2023 & 2033 (%)
  • Figure 90 North America Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ Billion)
  • Figure 91 North America Point of Care Diagnostics Market Share Forecast by Mode, 2023 & 2033 (%)
  • Figure 92 North America Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn)
  • Figure 93 North America Point of Care Diagnostics Market Share Forecast by Sample, 2023 & 2033 (%)
  • Figure 94 North America Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn)
  • Figure 95 North America Point of Care Diagnostics Market Share Forecast by Platform, 2023 & 2033 (%)
  • Figure 96 North America Point of Care Diagnostics Market Forecast by End Users, 2023-2033 (US$ bn)
  • Figure 97 North America Point of Care Diagnostics Market Share Forecast by End Users, 2023 & 2033 (%)
  • Figure 98 North America Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn)
  • Figure 99 North America Point of Care Diagnostics Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 100 U.S. Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 101 Canada Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 102 Europe Point of Care Diagnostics Market Attractiveness Index
  • Figure 103 Europe Point of Care Diagnostics Market by Region, 2023, 2028 & 2033 (US$ bn)
  • Figure 104 Europe Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn)
  • Figure 105 Europe Point of Care Diagnostics Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 106 Europe Point of Care Diagnostics Market Forecast By Product, 2023-2033 (US$ bn)
  • Figure 107 Europe Point of Care Diagnostics Market Share Forecast By Product, 2023 & 2033 (%)
  • Figure 108 Europe Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ bn)
  • Figure 109 Europe Point of Care Diagnostics Market Share Forecast by Mode, 2023 & 2033 (%)
  • Figure 110 Europe Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn)
  • Figure 111 Europe Point of Care Diagnostics Market Share Forecast by Sample, 2023 & 2033(%)
  • Figure 112 Europe Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn)
  • Figure 113 Europe Point of Care Diagnostics Market Share Forecast by Platform, 2023 & 2033 (%)
  • Figure 114 Europe Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn)
  • Figure 115 Europe Point of Care Diagnostics Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 116 Germany Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 117 UK Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 118 France Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 119 Italy Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 120 Spain Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 121 Netherlands Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 122 Rest of Europe Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 123 Asia Pacific Point of Care Diagnostics Market Attractiveness Index
  • Figure 124 Asia Pacific Point of Care Diagnostics Market by Region, 2023, 2028 & 2033 (US$ bn)
  • Figure 125 Asia Pacific Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn)
  • Figure 126 Asia Pacific Point of Care Diagnostics Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 127 Asia Pacific Point of Care Diagnostics Market Forecast By Product, 2023-2033 (US$ bn)
  • Figure 128 Asia Pacific Point of Care Diagnostics Market Share Forecast By Product, 2023 & 2033 (%)
  • Figure 129 Asia Pacific Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ bn)
  • Figure 130 Asia Pacific Point of Care Diagnostics Market Share Forecast by Mode, 2023 & 2033 (%)
  • Figure 131 Asia Pacific Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn)
  • Figure 132 Asia Pacific Point of Care Diagnostics Market Share Forecast by Sample, 2023 & 2033 (%)
  • Figure 133 Asia Pacific Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn)
  • Figure 134 Asia Pacific Point of Care Diagnostics Market Share Forecast by Platform, 2023 & 2033(%)
  • Figure 135 Asia Pacific Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn)
  • Figure 136 Asia Pacific Point of Care Diagnostics Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 137 Japan Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 138 China Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 139 India Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 140 Australia Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 141 South Korea Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 142 Rest of Asia Pacific Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 143 Latin America Point of Care Diagnostics Market Attractiveness Index
  • Figure 144 Latin America Point of Care Diagnostics Market by Region, 2023, 2028 & 2033 (US$ bn)
  • Figure 145 Latin America Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn)
  • Figure 146 Latin America Point of Care Diagnostics Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 147 Latin America Point of Care Diagnostics Market Forecast by Product, 2023-2033 (US$ bn)
  • Figure 148 Latin America Point of Care Diagnostics Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 149 Latin America Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ bn)
  • Figure 150 Latin America Point of Care Diagnostics Market Share Forecast by Mode, 2023 & 2033 (%)
  • Figure 151 Latin America Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn)
  • Figure 152 Latin America Point of Care Diagnostics Market Share Forecast by Sample, 2023 & 2033 (%)
  • Figure 153 Latin America Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn)
  • Figure 154 Latin America Point of Care Diagnostics Market Share Forecast by Platform, 2023 & 2033 (%)
  • Figure 155 Latin America Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn)
  • Figure 156 Latin America Point of Care Diagnostics Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 157 Brazil Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 158 Mexico Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 159 Rest of Latin America Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 160 MEA Point of Care Diagnostics Market Attractiveness Index
  • Figure 161 MEA Point of Care Diagnostics Market by Region, 2023, 2028 & 2033 (US$ bn)
  • Figure 162 MEA Point of Care Diagnostics Market Forecast by Country, 2023-2033 (US$ bn)
  • Figure 163 MEA Point of Care Diagnostics Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 164 MEA Point of Care Diagnostics Market Forecast By Product, 2023-2033 (US$ bn)
  • Figure 165 MEA Point of Care Diagnostics Market Share Forecast By Product, 2023 & 2033 (%)
  • Figure 166 MEA Point of Care Diagnostics Market Forecast by Mode, 2023-2033 (US$ bn)
  • Figure 167 MEA Point of Care Diagnostics Market Share Forecast by Mode, 2023 & 2033 (%)
  • Figure 168 MEA Point of Care Diagnostics Market Forecast by Sample, 2023-2033 (US$ bn)
  • Figure 169 MEA Point of Care Diagnostics Market Share Forecast by Sample, 2023 & 2033 (%)
  • Figure 170 MEA Point of Care Diagnostics Market Forecast by Platform, 2023-2033 (US$ bn)
  • Figure 171 MEA Point of Care Diagnostics Market Share Forecast by Platform, 2023 & 2033 (%)
  • Figure 172 MEA Point of Care Diagnostics Market Forecast by End-users, 2023-2033 (US$ bn)
  • Figure 173 MEA Point of Care Diagnostics Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 174 GCC Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 175 South Africa Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 176 Rest of MEA Point of Care Diagnostics Market Forecast, 2023-2033 (US$ bn, AGR %)
  • Figure 177 Point of Care Diagnostics Market: Company Share/Ranking, 2021
  • Figure 178 Abbott: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 179 Abbott: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 180 Abbott: Regional Market Shares, 2021
  • Figure 181 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 182 F. Hoffmann-La Roche Ltd: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 183 F. Hoffmann-La Roche Ltd: Regional Market Shares, 2021
  • Figure 184 Quidel Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 185 Quidel Corporation: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 186 Quidel Corporation: Regional Market Shares, 2021
  • Figure 187 Thermo Fisher Scientific.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 188 Thermo Fisher Scientific.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 189 Thermo Fisher Scientific.: Regional Market Shares, 2021
  • Figure 190 BD: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 191 BD : R & D, 2017-2021 (US$ million, AGR%)
  • Figure 192 BD: Regional Market Shares, 2021
  • Figure 193 Danaher: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 194 Danaher: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 195 Danaher: Regional Market Shares, 2021
  • Figure 196 Trinity Biotech Ireland: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 197 Trinity Biotech Ireland: Regional Market Shares, 2021
  • Figure 198 Siemens Healthcare GmbH: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 199 Siemens Healthcare GmbH: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 200 Siemens Healthcare GmbH: Regional Market Shares, 2021
  • Figure 201 Chembio Diagnostics Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 202 Chembio Diagnostics Inc: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 203 Chembio Diagnostics Inc.: Regional Market Shares, 2021
  • Figure 204 Werfen: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 205 Werfen: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 206 Werfen: Regional Market Shares, 2021
  • Figure 207 Qiagen: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 208 Qiagen: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 209 Qiagen: Regional Market Shares, 2021
  • Figure 210 bioMerieux SA: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 211 bioMerieux SA: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 212 bioMerieux SA: Regional Market Shares, 2021
  • Figure 213 Nipro Europe Group Companies: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 214 Nipro Europe Group Companies: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 215 Nipro Europe Group Companies: Regional Market Shares, 2021
  • Figure 216 EKF Diagnostics: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 217 EKF Diagnostics: Regional Market Shares, 2021
  • Figure 218 Orasure Technologies, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 219 Orasure Technologies, Inc.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 220 Orasure Technologies, Inc.: Regional Market Shares, 2021
  • Figure 221 LumiraDX.: Net Revenue, 2019-2021 (US$ million, AGR%)
  • Figure 222 LumiraDX.: R&D, 2019-2021 (US$ million, AGR%)
  • Figure 223 Meridian Bioscience Inc..: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 224 Meridian Bioscience Inc..: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 225 Meridian Bioscience Inc..: Regional Market Shares, 2021
目次
Product Code: PHA1224

The global Point of Care Diagnostics market is projected to grow at a CAGR of 8.8% by 2033.

“The Point of Care Diagnostics Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Incidence of Target Conditions and Rising Number of CLIA Waived POC Tests Are Driving the Market Growth

Target conditions for POC testing are illnesses or disorders that require ongoing monitoring, such as diabetes, hemophilia, cancer, and cardiac problems. The adoption of POC testing equipment can therefore be attributed in large part to the rising incidence and prevalence of these illnesses. Diabetes is a serious, chronic disorder that can significantly affect people's lives, wellbeing, and families all around the world. According to IDF, in 2021, there were 537 million diabetics worldwide between the ages of 20 and 79.

CLIA defines waived tests as straightforward laboratory investigations and procedures with a very low chance of producing an erroneous result. In addition to approving manufacturer petitions for test system waivers, the Food and Drug Administration (FDA) determines what standards testing must follow in terms of being simple and error prone. The Binx health io CT/NG test, a molecular platform used to detect STDs such as chlamydia and gonorrhea at the point of treatment, acquired a CLIA waiver from the US FDA in April 2021, according to a statement released at the time

Stringent and Time-Consuming Regulatory Policies Likely to Challenge Market Growth

The complicated FDA regulations and CLIA laboratory standards present manufacturers with some regulatory challenges despite the rising demand for POC equipment (for the premarket approval of POC testing kits). Manufacturers must provide performance data to the FDA for any new POC equipment to be approved in the United States. This should show that people and healthcare professionals can use these tools and get outcomes that are comparable to those of clinical laboratory tests. For in vitro diagnostic (IVD) equipment as opposed to non-IVD ones, the amount of examination is also rather exceptional. For instance, the FDA typically waits until the intended application, conditions for usage, target patient demographic, and test performance characteristics remain intact before re-examining approved prescription non-IVD devices for use in new situations. Though under this rule POC devices are not covered.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the point of care diagnostics market evolving?
  • What is driving and restraining the point of care diagnostics market?
  • How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each point of care diagnostics submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading point of care diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the point of care diagnostics projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of point of care diagnostics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the point of care diagnostics market?
  • Where is the point of care diagnostics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the point of care diagnostics market today, and over the next 10 years:

  • Our 352-page report provides 158 tables, 225 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the point of care diagnostics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising point of care diagnostics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Product

  • Glucose Monitoring
  • Cardiometabolic Monitoring
  • Infectious Disease Testing
  • Coagulation Monitoring
  • Pregnancy & Fertility Testing
  • Tumor/Cancer Marker Testing
  • Urinalysis Testing
  • Cholesterol Testing
  • Hematology Testing
  • Drugs-of-abuse Testing
  • Fecal Occult Testing
  • Other POC Products

Mode

  • Prescription-based
  • OTC

Sample

  • Blood
  • Nasal and Oropharyngeal Swabs
  • Urine
  • Other

Platform

  • Lateral Flow Assay
  • Dipstick
  • Microfluidics
  • Molecular diagnostics
  • Immunoassay

End User

  • Clinics
  • Hospitals
  • Home Care Setting
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Point of Care Diagnostics Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Abbott
  • AccuBioTech Co., Ltd
  • BD
  • bioMerieux SA
  • Chembio Diagnostics, Inc.
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd
  • Fluxergy
  • LumiraDx
  • Meridian Bioscience
  • Nipro Europe Group Companies
  • Nova Biomedical
  • Orasure Technologies, Inc.
  • PTS Diagnostics
  • Qiagen
  • Quidel Corporation
  • Response Biomedical
  • Sekisui Diagnostics
  • Siemens Healthcare GmbH
  • Spectral Medical Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Ireland
  • Trividia Health, Inc.
  • Werfen

Overall world revenue for Point of Care Diagnostics Market, 2023 to 2033 in terms of value the market will surpass US$43 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Point of care diagnostics Market, 2023 to 2033 report help you?

In summary, our 350+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Point of Care Diagnostics Market, 2023 to 2033 Market, with forecasts for product, mode, sample, platform, end user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the Point of Care Diagnostics Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Netherlands, China, India, Japan, Australia, South Korea, Brazil, GCC, and South Africa among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Point of Care Diagnostics Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Point of Care Diagnostics Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Point of Care Diagnostics Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 High Prevalence of Infectious Diseases Across the Globe
      • 3.2.1.2 Increasing Incidence of Target Conditions
      • 3.2.1.3 Growing Government Support
      • 3.2.1.4 Rising Number of CLIA Waived POC Tests
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
      • 3.2.2.2 Stringent and Time-Consuming Regulatory Policies
    • 3.2.3 Market Opportunities
      • 3.2.3.1 POC Tests with Multiplexing Capabilities
      • 3.2.3.2 Healthcare Decentralization - Converting Lab Tests to POC Tests
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Low Bargaining Power of Supplier
    • 3.4.2 High Bargaining Power of Buyer
    • 3.4.3 Low Threat of New Entrants
    • 3.4.4 High Threat of Substitutes
    • 3.4.5 High Intensity of Competitive Rivalry
  • 3.5 PEST Analysis
  • 3.6 SWOT Analysis

4 Point of Care Diagnostics Market, by Product, 2023-2033

  • 4.1 Key Findings
  • 4.2 Product Segment: Market Attractiveness Index
  • 4.3 Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 4.4 Glucose Monitoring
    • 4.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Cardiometabolic Monitoring
    • 4.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6 Infectious Disease Testing
    • 4.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.7 Coagulation Monitoring
    • 4.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.7.2 Market Share by Region, 2023 & 2033 (%)
  • 4.8 Pregnancy & Fertility Testing
    • 4.8.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.8.2 Market Share by Region, 2023 & 2033 (%)
  • 4.9 Tumour/Cancer Marker Testing
    • 4.9.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.9.2 Market Share by Region, 2023 & 2033 (%)
  • 4.10 Urinalysis Testing
    • 4.10.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.10.2 Market Share by Region, 2023 & 2033 (%)
  • 4.11 Cholesterol Testing
    • 4.11.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.11.2 Market Share by Region, 2023 & 2033 (%)
  • 4.12 Hematology Testing
    • 4.12.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.12.2 Market Share by Region, 2023 & 2033 (%)
  • 4.13 Drugs-of-abuse Testing
    • 4.13.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.13.2 Market Share by Region, 2023 & 2033 (%)
  • 4.14 Fecal Occult Testing
    • 4.14.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.14.2 Market Share by Region, 2023 & 2033 (%)
  • 4.15 Other POC Products
    • 4.15.1 Market Size by Region, 2023-2033 (US$ bn)
    • 4.15.2 Market Share by Region, 2023 & 2033 (%)

5 Point of Care Diagnostics Market, by Mode, 2023-2033

  • 5.1 Key Findings
  • 5.2 Mode Segment: Market Attractiveness Index
  • 5.3 Point of Care Diagnostics Market, by Mode
  • 5.4 Prescription-based Products
    • 5.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Over the Counter (OTC) Products
    • 5.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Point of Care Diagnostics Market, by Sample, 2023-2033

  • 6.1 Key Findings
  • 6.2 Sample Segment: Market Attractiveness Index
  • 6.3 Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 6.4 Blood
    • 6.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Nasal and Oropharyngeal Swabs
    • 6.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Urine
    • 6.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Other
    • 6.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Point of Care Diagnostics Market, by Platform, 2023-2033

  • 7.1 Key Findings
  • 7.2 Platform Segment: Market Attractiveness Index
  • 7.3 Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 7.4 Lateral Flow Assay
    • 7.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Dipstick
    • 7.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Microfluidics
    • 7.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)
  • 7.7 Molecular diagnostics
    • 7.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.7.2 Market Share by Region, 2023 & 2033 (%)
  • 7.8 Immunoassay
    • 7.8.1 Market Size by Region, 2023-2033 (US$ bn)
    • 7.8.2 Market Share by Region, 2023 & 2033 (%)

8 Point of Care Diagnostics Market, by End User, 2023-2033

  • 8.1 Key Findings
  • 8.2 End User Segment Market Attractiveness Index
  • 8.3 Point of Care Diagnostics Market Size Estimation and Forecast by End User
  • 8.4 Clinics
    • 8.4.1 Market Size by Region, 2023-2033 (US$ bn)
    • 8.4.2 Market Share by Region, 2023 & 2033 (%)
  • 8.5 Hospitals
    • 8.5.1 Market Size by Region, 2023-2033 (US$ bn)
    • 8.5.2 Market Share by Region, 2023 & 2033 (%)
  • 8.6 Home Care Settings
    • 8.6.1 Market Size by Region, 2023-2033 (US$ bn)
    • 8.6.2 Market Share by Region, 2023 & 2033 (%)
  • 8.7 Other End-users
    • 8.7.1 Market Size by Region, 2023-2033 (US$ bn)
    • 8.7.2 Market Share by Region, 2023 & 2033 (%)

9 Point of Care Diagnostics Market Analysis by Region, 2023-2033

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Point of Care Diagnostics Market, 2023-2033

  • 10.1 Key Findings
  • 10.2 North America Point of Care Diagnostics Market Attractiveness Index
  • 10.3 North America Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 10.4 North America Point of Care Diagnostics Market Forecast by Product
  • 10.5 North America Point of Care Diagnostics Market Forecast by Mode
  • 10.6 North America Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 10.7 North America Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 10.8 North America Point of Care Diagnostics Market Size Estimation and Forecast by End Users
  • 10.9 North America Point of Care Diagnostics Market Forecast by Country
  • 10.10 U.S. Point of Care Diagnostics Market Analysis
  • 10.11 Canada Point of Care Diagnostics Market Analysis

11 Europe Point of Care Diagnostics Market, 2023-2033

  • 11.1 Key Findings
  • 11.2 Europe Point of Care Diagnostics Market Attractiveness Index
  • 11.3 Europe Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 11.4 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Country
  • 11.5 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 11.6 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Mode
  • 11.7 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 11.8 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 11.9 Europe Point of Care Diagnostics Market Size Estimation and Forecast by End-users
  • 11.10 Germany Point of Care Diagnostics Market Analysis
  • 11.11 UK Point of Care Diagnostics Market Analysis
  • 11.12 France Point of Care Diagnostics Market Analysis
  • 11.13 Italy Point of Care Diagnostics Market Analysis
  • 11.14 Spain Point of Care Diagnostics Market Analysis
  • 11.15 Netherlands Point of Care Diagnostics Market Analysis
  • 11.16 Rest of Europe Point of Care Diagnostics Market Analysis

12 Asia Pacific Point of Care Diagnostics Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Pacific Point of Care Diagnostics Market Attractiveness Index
  • 12.3 Asia Pacific Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 12.4 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Country
  • 12.5 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 12.6 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Mode
  • 12.7 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 12.8 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 12.9 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by End-users
  • 12.10 Japan Point of Care Diagnostics Market Analysis
  • 12.11 China Point of Care Diagnostics Market Analysis
  • 12.12 India Point of Care Diagnostics Market Analysis
  • 12.13 Australia Point of Care Diagnostics Market Analysis
  • 12.14 South Korea Point of Care Diagnostics Market Analysis
  • 12.15 Rest of Asia Pacific Point of Care Diagnostics Market Analysis

13 Latin America Point of Care Diagnostics Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Point of Care Diagnostics Market Attractiveness Index
  • 13.3 Latin America Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 13.4 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Country
  • 13.5 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 13.6 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Mode
  • 13.7 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 13.8 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 13.9 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by End-users
  • 13.10 Brazil Point of Care Diagnostics Market Analysis
  • 13.11 Mexico Point of Care Diagnostics Market Analysis
  • 13.12 Rest of Latin America Point of Care Diagnostics Market Analysis

14 MEA Point of Care Diagnostics Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Point of Care Diagnostics Market Attractiveness Index
  • 14.3 MEA Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 14.4 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Country
  • 14.5 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Product
  • 14.6 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Mode
  • 14.7 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Sample
  • 14.8 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Platform
  • 14.9 MEA Point of Care Diagnostics Market Size Estimation and Forecast by End-users
  • 14.10 GCC Point of Care Diagnostics Market Analysis
  • 14.11 South Africa Point of Care Diagnostics Market Analysis
  • 14.12 Rest of MEA Point of Care Diagnostics Market Analysis

15 Company Profiles

  • 15.1 Competitive Landscape, 2021
  • 15.2 Abbott
    • 15.2.1 Company Snapshot
    • 15.2.2 Company Overview
    • 15.2.3 Financial Analysis
      • 15.2.3.1 Net Revenue, 2017-2021
      • 15.2.3.2 R&D, 2017-2021
      • 15.2.3.3 Regional Market Shares, 2021
    • 15.2.4 Product Benchmarking
    • 15.2.5 Strategic Outlook
  • 15.3 F. Hoffmann-La Roche Ltd
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
      • 15.3.3.1 Net Revenue, 2017-2021
      • 15.3.3.2 R&D, 2017-2021
      • 15.3.3.3 Regional Market Shares, 2021
    • 15.3.4 Product Benchmarking
    • 15.3.5 Strategic Outlook
  • 15.4 Quidel Corporation
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Financial Analysis
      • 15.4.3.1 Net Revenue, 2017-2021
      • 15.4.3.2 R&D, 2017-2021
      • 15.4.3.3 Regional Market Shares, 2021
    • 15.4.4 Product Benchmarking
    • 15.4.5 Strategic Outlook
  • 15.5 AccuBioTech Co., Ltd
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Product Benchmarking
    • 15.5.4 Strategic Outlook
  • 15.6 Thermo Fisher Scientific
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Financial Analysis
      • 15.6.3.1 Net Revenue, 2017-2021
      • 15.6.3.2 R&D, 2017-2021
    • 15.6.4 Product Benchmarking
    • 15.6.5 Strategic Outlook
  • 15.7 BD
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
      • 15.7.3.1 Net Revenue, 2017-2021
      • 15.7.3.2 R & D, 2017-2021
      • 15.7.3.3 Regional Market Shares, 2021
    • 15.7.4 Product Benchmarking
    • 15.7.5 Strategic Outlook
  • 15.8 Danaher
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2017-2021
      • 15.8.3.2 R&D, 2017-2021
      • 15.8.3.3 Regional Market Shares, 2021
    • 15.8.4 Product Benchmarking
    • 15.8.5 Strategic Outlook
  • 15.9 PTS Diagnostics
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Product Benchmarking
  • 15.10 Trinity Biotech Ireland
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Financial Analysis
      • 15.10.3.1 Net Revenue, 2017-2021
      • 15.10.3.2 Regional Market Shares, 2021
    • 15.10.4 Product Benchmarking
    • 15.10.5 Strategic Outlook
  • 15.11 Siemens Healthcare GmbH
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Financial Analysis
      • 15.11.3.1 Net Revenue, 2017-2021
      • 15.11.3.2 R&D, 2017-2021
      • 15.11.3.3 Regional Market Shares, 2021
    • 15.11.4 Product Benchmarking
    • 15.11.5 Strategic Outlook
  • 15.12 Sekisui Diagnostics
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Product Benchmarking
    • 15.12.4 Strategic Outlook
  • 15.13 Fluxergy
    • 15.13.1 Company Snapshot
    • 15.13.2 Company Overview
    • 15.13.3 Product Benchmarking
    • 15.13.4 Strategic Outlook
  • 15.14 Chembio Diagnostics Inc.
    • 15.14.1 Company Snapshot
    • 15.14.2 Company Overview
    • 15.14.3 Financial Analysis
      • 15.14.3.1 Net Revenue, 2017-2021
      • 15.14.3.2 R&D, 2017-2021
      • 15.14.3.3 Regional Market Shares, 2021
    • 15.14.4 Product Benchmarking
    • 15.14.5 Strategic Outlook
  • 15.15 Werfen
    • 15.15.1 Company Snapshot
    • 15.15.2 Company Overview
    • 15.15.3 Financial Analysis
      • 15.15.3.1 Net Revenue, 2017-2021
      • 15.15.3.2 R&D, 2017-2021
      • 15.15.3.3 Regional Market Shares, 2021
    • 15.15.4 Product Benchmarking
  • 15.16 NOVA BIOMEDICAL
    • 15.16.1 Company Snapshot
    • 15.16.2 Company Overview
    • 15.16.3 Product Benchmarking
  • 15.17 Qiagen
    • 15.17.1 Company Snapshot
    • 15.17.2 Company Overview
    • 15.17.3 Financial Analysis
      • 15.17.3.1 Net Revenue, 2017-2021
      • 15.17.3.2 R&D, 2017-2021
      • 15.17.3.3 Regional Market Shares, 2021
    • 15.17.4 Product Benchmarking
    • 15.17.5 Strategic Outlook
  • 15.18 bioMerieux SA
    • 15.18.1 Company Snapshot
    • 15.18.2 Company Overview
    • 15.18.3 Financial Analysis
      • 15.18.3.1 Net Revenue, 2017-2021
      • 15.18.3.2 R&D, 2017-2021
      • 15.18.3.3 Regional Market Shares, 2021
    • 15.18.4 Product Benchmarking
    • 15.18.5 Strategic Outlook
  • 15.19 Nipro Europe Group Companies
    • 15.19.1 Company Snapshot
    • 15.19.2 Company Overview
    • 15.19.3 Financial Analysis
      • 15.19.3.1 Net Revenue, 2017-2021
      • 15.19.3.2 R&D, 2017-2021
      • 15.19.3.3 Regional Market Shares, 2021
    • 15.19.4 Product Benchmarking
    • 15.19.5 Strategic Outlook
  • 15.20 EKF Diagnostics Holdings plc
    • 15.20.1 Company Snapshot
    • 15.20.2 Company Overview
    • 15.20.3 Financial Analysis
      • 15.20.3.1 Net Revenue, 2017-2021
      • 15.20.3.2 Regional Market Shares, 2021
    • 15.20.4 Product Benchmarking
    • 15.20.5 Strategic Outlook
  • 15.21 TRIVIDIA HEALTH, INC.
    • 15.21.1 Company Snapshot
    • 15.21.2 Company Overview
    • 15.21.3 Product Benchmarking
  • 15.22 Spectral Medical Inc.
    • 15.22.1 Company Snapshot
    • 15.22.2 Company Overview
    • 15.22.3 Product Benchmarking
  • 15.23 Orasure Technologies, Inc.
    • 15.23.1 Company Snapshot
    • 15.23.2 Company Overview
    • 15.23.3 Financial Analysis
      • 15.23.3.1 Net Revenue, 2017-2021
      • 15.23.3.2 R&D, 2017-2021
      • 15.23.3.3 Regional Market Shares, 2021
    • 15.23.4 Product Benchmarking
    • 15.23.5 Strategic Outlook
  • 15.24 Response Biomedical
    • 15.24.1 Company Snapshot
    • 15.24.2 Company Overview
    • 15.24.3 Product Benchmarking
    • 15.24.4 Strategic Outlook
  • 15.25 LumiraDX
    • 15.25.1 Company Snapshot
    • 15.25.2 Company Overview
    • 15.25.3 Financial Analysis
      • 15.25.3.1 Net Revenue, 2019-2021
      • 15.25.3.2 R&D, 2019-2021
    • 15.25.4 Product Benchmarking
    • 15.25.5 Strategic Outlook
  • 15.26 Meridian Bioscience Inc.
    • 15.26.1 Company Snapshot
    • 15.26.2 Company Overview
    • 15.26.3 Financial Analysis
      • 15.26.3.1 Net Revenue, 2017-2021
      • 15.26.3.2 R&D, 2017-2021
      • 15.26.3.3 Regional Market Shares, 2021
    • 15.26.4 Product Benchmarking
    • 15.26.5 Strategic Outlook

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from
  • 16.2 Recommendations for Market Players